Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial
eClinicalMedicine(2023)
摘要
The study was sponsored by Inotrem SA.
更多查看译文
关键词
COVID-19,TREM-1,Clinical trial,SARS-CoV-2,ICU,Pneumonia,ARDS
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要